Safety, Tolerability, and Pharmacokinetics of Once-Monthly Oral Islatravir: A Phase 2a Study in Participants at Low Risk for Acquiring Human Immunodeficiency Virus Type 1

Journal:
Journal of Infectious Diseases
Published:
DOI:
10.1093/infdis/jiaf222
Affiliations:
9
Authors:
23
Go to article
Institutions Authors Share
Merck Research Laboratories (MRL), United States of America (USA)
13.000000
13.000000
 0.57
University of Cape Town (UCT), South Africa
3.000000
 0.13
Health Sciences, Pitt, United States of America (USA)
1.500000
 0.07
Johns Hopkins Hospital, United States of America (USA)
1.000000
 0.04
University of the Witwatersrand, Johannesburg (Wits University), South Africa
1.000000
 0.04
Josha Research, South Africa
1.000000
 0.04
Hadassah Medical Center, HUJI, Israel
1.000000
 0.04
Rambam Health Care Campus (RambamHCC), IIT, Israel
1.000000
 0.04
Magee-Womens Research Institute (MWRI), Pitt, United States of America (USA)
0.500000
 0.02
Interested in Clinical Sciences?